Twist Bioscience

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries.[2] Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.

Twist Bioscience
Company typePublic
Industrysynthetic biology
Founded2013; 11 years ago (2013)
Founders
Headquarters
ProductsGenes and gene fragments, NGS products
RevenueIncrease $54.2 million(2019)[1]
Number of employees
400
Websitetwistbioscience.com

The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.[3]

In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.[4]

References